UKCA Marking Debate Moves To Next Level: All Eyes On The MHRA
Industry is concerned about the UK regulator’s ability to create the certainty needed for a successful medtech market
The MHRA is under pressure to deliver a new sovereign devices regulatory system in the tightest of timelines for the post-Brexit UK market. It has had no lack of support in this endeavor from system users, but industry is now keen to see the regulator deliver on its two-year plan issued in 2021, says the ABHI’s Phil Brown, in this first part of a two-part industry view of future UK needs.
